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CONTINUING PROFESSIONAL DEVELOPMENT
PEARLS COCHRANE CORNER
String of PEARLS
DISCLAIMER: PEARLS are for educational use only and are not meant 
to guide clinical activity, nor are they a clinical guideline.
Practical Evidence About Real Life Situations
Stroke
MRI may be more sensitive than CT imaging for early 
detection of stroke
Percutaneous vascular interventions may be beneficial 
in stroke 
Insufficient evidence for benefits of very early 
mobilisation after stroke
Electromechanical-assisted training improves walking 
after stroke
Mirror therapy improves motor function after stroke
Repetitive task training can improve functional ability 
after stroke
Insufficient evidence for interventions for post-stroke 
fatigue
All people residing in New Zealand have access to the Cochrane Library 
via the Ministry website www.health.govt.nz/cochrane-library
PEARLS are succinct summaries of Cochrane Systematic Reviews for 
primary care practitioners—developed by Prof. Brian McAvoy for the 
Cochrane Primary Care Field (www.cochraneprimarycare.org), New 
Zealand Branch of the Australasian Cochrane Centre at the Department 
of General Practice and Primary Health Care, University of Auckland 
(www.auckland.ac.nz/uoa), funded by the Ministry of Health (www.
health.govt.nz), and published in NZ Doctor (www.nzdoctor.co.nz.).
THE PROBLEM: The presentation of subclinical hypothy-
roidism (or mild thyroid failure) is often vague, with the 
non-specific symptoms of actual hypothyroidism, such as dry 
skin, cold skin or feeling colder, constipation and cognitive 
disturbance (e.g. slower thinking and poor memory). This is 
a common complaint, affecting 3% of men and 8% of women, 
with prevalence rising sharply in older age.1 As the symptoms 
of subclinical hypothyroidism are non-specific, diagnosis is 
made if a patient’s serum thyroid-stimulating hormone (TSH) 
level is above the upper limit of normal despite normal levels 
of serum free thyroxine.2 There is debate over whether this 
condition should be treated, as the impact of subclinical hypo-
thyroidism on patients’ health remains unclear. 
CLINICAL BOTTOM LINE: Levothyroxine replacement 
therapy does not improve symptoms or quality of life when 
compared to placebo in patients with subclinical hypothyroid-
ism. However, there is some evidence that thyroid hormone 
replacement may improve some parameters of lipid profiles and 
left ventricular function.
Thyroid hormone replacement for subclinical hypothyroidism
Success Evidence Harms
Symptom score 
change
Improvement in 
total cholesterol 
level 
Improvement in 
quality of life 
Non-significant 
difference between 
intervention and placebo
Non-significant 
difference between 
intervention and placebo
Non-significant 
difference between 
intervention and placebo 
Cochrane 
review3
Insufficient 
data to 
determine 
harms
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